Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas

Blood

Volumn 104, Issue 2, 2004, Pages 502-508

  Trentin, Livio ^b   Cabrelle, Anna ^b   Facco, Monica ^b   Carollo, Davide ^b   Miorin, Marta ^b   Tosoni, Alicia ^b   Pizzo, Paola ^b   Binotto, Gianni ^b   Nicolardi, Linda ^b   Zambello, Renato ^b   Adami, Fausto ^b   Agostini, Carlo ^b   Semenzato, Gianpietro ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCL13; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR12; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR5; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE SUBPOPULATION; CELL SUSPENSION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; FEMALE; FLOW CYTOMETRY; FOLLICULAR CELL LYMPHOMA; HAIRY CELL LEUKEMIA; HOMEOSTASIS; HUMAN; HUMAN CELL; MALE; MANTLE CELL LYMPHOMA; MARGINAL ZONE B CELL LYMPHOMA; METASTASIS; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMALL LYMPHOCYTIC LYMPHOMA;

EID: 3142559469     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-09-3103     Document Type: Article

References (46)

1. Baggiolini M, Dewald B, Moser B. Human chemokines, an update. Annu Rev Immunol. 1997;15:675-705.
2. Baggiolini M. Chemokines and leukocyte traffic. Nature. 1998;392:565-568.
3. Jung S, Littman DR. Chemokine receptors in lymphoid organ homeostasis. Curr Opin Immunol. 1999;11:319-325.
4. Cyster JG. Chemokines and cell migration in secondary lymphoid organs. Science. 1999;286:2098-2102.
5. Loetscher P, Moser B, Baggiolini M. Chemokines and their receptors in lymphocyte traffic and HIV infection. Adv Immunol. 2000;74:127-180.
6. Yoshie O, Imai T, Nomiyama H. Novel lymphocytes-specific CC chemokines and their receptors. J Leukoc Biol. 1997;62:634-644.
7. Murphy PM, Baggiolini M, Charo IF, et al. International Union of Pharmacology, XXII: nomenclature for chemokine receptors. Pharmacol Rev. 2000;52:145-176.
8. Muller G, Hopken UE, Stein H, Lipp M. Systemic immunoregulatory and pathogenic functions of homeostatic chemokine receptors. J Leukoc Biol. 2002;72:1-8.
9. Bowman EP, Campbell JJ, Soler D, et al. developmental switches in chemokine response profiles during B cell differentiation and maturation. J Exp Med. 2000;191:1303-1317.
10. Tashiro K, Tada H, Heilker R, Shirozu M, Nakano T, Honjo T. Signal sequence trap: a cloning strategy for secreted proteins and type 1 membrane proteins. Science. 1993;261:600-603.
11. Nagasawa T, Hirota S, Tachibana K, et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature. 1996;382:635-638.
12. Tachibana K, Hirota S, Iizasa H, et al. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract [see comments]. Nature. 1998;393:591-594.
13. Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development [see comments]. Nature. 1998;393:595-599.
14. Trentin L, Agostini C, Facco M, et al. The chemokine receptor CXCR3 is expressed on malignant B cells and mediates chemotaxis. J Clin Invest. 1999;104:115-121.
15. Burger JA, Burger M, Kipps TJ. Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells. Blood. 1999;94:3658-3667.
16. Jones D, Benjamin RJ, Shahsafaei A, Dorfman DM. The chemokine receptor CXCR3 is expressed in a subset of B-cell lymphomas and is a marker of B-cell chronic lymphocytic leukemia. Blood. 2000;95:627-632.
17. Mazzucchelli L, Blaser A, Kappeler A, et al. BCA-1 is highly expressed in Helicobacter pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma [see comments]. J Clin Invest. 1999;104:R49-R54.
18. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84:1361-1392.
19. Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS. Clinical staging of chronic lymphocytic leukemia. Blood. 1975;46:219-234.
20. Trentin L, Zambello R, Agostini C, et al. Mechanisms accounting for the defective natural killer activity in patients with hairy cell leukemia. Blood. 1990;75:1525-1530.
21. Cerutti A, Trentin L, Zambello R, et al. The CD5/ CD72 receptor system is coexpressed with several functionally relevant counterstructures on human B cells and delivers a critical signaling activity. J Immunol. 1996;157:1854-1862.
22. Trentin L, Zambello R, Sancetta R, et al. B lymphocytes from patients with chronic lymphoproliferative disorders are equipped with different costimulatory molecules. Cancer Res. 1997;57:4940-4947.
23. Trentin L, Zambello R, Agostini C, et al. Expression and regulation of tumor necrosis factor, interleukin-2, and hematopoietic growth factor receptors in B-cell chronic lymphocytic leukemia. Blood. 1994;84:4249-4256.
24. 2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985;260:3440-3450.
25. Di Virgilio F, Steinberg TH, Swanson JA, Silverstein SC. Fura-2 secretion and sequestration in macrophages. A blocker of organic anion transport reveals that these processes occur via a membrane transport system for organic anions. J Immunol. 1988;140:915-920.
26. Ma Q, Jones D, Borghesani PR, et al. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc Natl Acad Sci U S A. 1998;95:9448-9453.
27. Bleul CC, Fuhlbrigge RC, Casasnovas JM, Aiuti A, Springer TA. A high efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med. 1996;184:1101-1109.
28. Ma Q, Jones D, Springer TA. The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. Immunity. 1999;10:463-471.
29. Nagasawa T. Kikutani H, Kishimoto T. Molecular cloning and structure of a pre-B-cell growth-stimulating factor, Proc Natl Acad Sci U S A. 1994;91:2305-2309.
30. Bleul CC, Schultze JL, Springer TA. B lymphocyte chemotaxis regulated in association with microanatomic localization, differentiation state, and B cell receptor engagement. J Exp Med. 1998;187:753-762.
31. Fedyk ER, Ryyan DH, Ritterman I, Springer TA. Maturation decreases responsiveness of human bone marrow B lineage cells to stromal-derived factor 1 (SDF-1). J Leukoc Biol. 1999;66:667-673.
32. Legler DF, Loetscher M, Roos RS, Clark-Lewis I, Baggiolini M, Moser B. B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J Exp Med. 1998;187:655-660.
33. Forster R, Emrich T, Kremmer E, Lipp M. Expression of the G-protein-coupled receptor BLR1 defines mature, recirculating B cells and a subset of T-helper memory cells. Blood. 1994;84:830-840.
34. Forster R, Mattis AE, Kremmer E, Wolf E, Brem G, Lipp M. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell. 1996;87:1037-1047.
35. Ngo VN, Korner H, Gunn MD, et al. Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen. J Exp Med. 1999;189:403-412.
36. Digel W, Stefanic M, Schoniger W, et al. Tumor necrosis factor induces proliferation of neoplastic B cells from chronic lymphocytic leukemia. Blood. 1989;73:1242-1246.
37. Diget W, Schoniger W, Stefanic M, et al. Receptors for tumor necrosis factor on neoplastic B cells from chronic lymphocytic leukemia are expressed in vitro but not in vivo. Blood. 1990;76:1607-1613.
38. Trentin L, Zambello R, Pizzoto G, et al. Tumor necrosis factor-alpha and B cell growth factor induce leukemic hairy cells to proliferate in vitro. Cancer Detect Prev. 1991;15:385-390.
39. Trentin L, Zambello R, Agostini C, et al. Expression and functional role of tumor necrosis factor receptors on leukemic cells from patients with type B chronic lymphoproliferative disorders. Blood. 1993;81:752-758.
40. Foà R, Massaia M, Cardona S, et al. Production of tumor necrosis factor alpha (TNF) by B-cell chronic lymphocytic leukemia cells: a possible regulatory role of TNF in the progression of the disease. Blood. 1990;76:393-400.
41. Foa R, Guarini A, Francia di Celle P, et al. Constitutive production of tumor necrosis factor-alpha in hairy cell leukemia: possible role in the pathogenesis of the cytopenia(s) and effects of treatment with interferon-alpha. J Clin Oncol. 1992;10:954-959.
42. Baba M, Imai T, Nishimura M, et al. Identification of CCR6, the specific receptor for a novel lymphocyte-directed CC chemokine LARC. J Biol Chem. 1997;272:14893-14898.
43. Liao F, Rabin RL, Smith CS, Sharma G, Nutman TB, Farber JM. CC-chemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3 alpha. J Immunol. 1999;162:186-194.
44. Rodig SJ, Jones D, Shahsafaei A, Dorfman DM. CCR6 is a functional chemokine receptor that serves to identify select B-cell non-Hodgkin's lymphomas. Hum Pathol. 2002;33:1227-1233.
45. Kim CH, Pelus LM, White JR, Applebaum E, Johanson K, Broxmeyer HE. CK beta-11/macrophage inflammatory protein-3 beta/EB11-ligand chemokine is an efficacious chemoattractant for T and B cells. J Immunol. 1998;160:2418-2424.
46. Schall TJ, Bacon K, Camp RD, Kaspari JW, Goeddel DV. Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes. J Exp Med. 1993;177:1821-1826.